Annovis Bio Stock Analysis

Annovis Stock Analysis Notes

About 20.0% of the company shares are held by company insiders. The company recorded a loss per share of 4.22. Annovis Bio had not issued any dividends in recent years. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people. For more info on Annovis Bio please contact Maria Maccecchini at (484) 875-3192 or go to https://www.annovisbio.com.

Annovis Bio Investment Alerts

Annovis Bio Upcoming and Recent Events

Annovis Largest EPS Surprises

View All Earnings Estimates

Annovis Bio Environmental, Social, and Governance (ESG) Scores

Annovis Stock Institutional Investors

Note, although Annovis Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Annovis Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 90.51 M.

Annovis Profitablity

Management Efficiency

Annovis Bio has return on total asset (ROA) of (1.5458) % which means that it has lost $1.5458 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.967) %, meaning that it created substantial loss on money invested by shareholders. Annovis Bio's management efficiency ratios could be used to measure how well Annovis Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 7.61 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (5.23). At this time, Annovis Bio's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 53.7 M in 2024, despite the fact that Return On Tangible Assets are likely to grow to (5.23).

Technical Drivers

As of the 27th of November, Annovis Bio shows the Standard Deviation of 4.29, mean deviation of 3.26, and Risk Adjusted Performance of (0.08). Annovis Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Annovis Bio standard deviation and potential upside to decide if Annovis Bio is priced correctly, providing market reflects its regular price of 6.56 per share. Given that Annovis Bio has information ratio of (0.15), we suggest you to validate Annovis Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Annovis Bio Price Movement Analysis

Annovis Bio Insider Trading Activities

Annovis Bio Outstanding Bonds

Annovis Bio Predictive Daily Indicators

Annovis Bio Corporate Filings

Annovis Bio Forecast Models

Annovis Bio's time-series forecasting models are one of many Annovis Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Annovis Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Annovis Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Annovis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Annovis Bio. By using and applying Annovis Stock analysis, traders can create a robust methodology for identifying Annovis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Annovis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Annovis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Annovis Bio stock analysis indicators help investors evaluate how Annovis Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Annovis Bio shares will generate the highest return on investment. By understating and applying Annovis Bio stock analysis, traders can identify Annovis Bio position entry and exit signals to maximize returns.

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.